Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003
Cigarette smoke-induced IL-8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol Source: Eur Respir J 2005; 26: Suppl. 49, 14s Year: 2005
Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003
Inhibition by roflumilast vs cilomilast of pulmonary leukocyte accumulation and TNFα release in a rat model of LPS-induced pulmonary neutrophilia Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003
Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Proteoglycan production in cultured human lung fibroblasts is synergistcally inhibited by combination of budesonide and formoterol Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells Source: Eur Respir J 2008; 31: 1313-1321 Year: 2008
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells Source: Eur Respir J 2001; 17: 1070-1077 Year: 2001
The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Budesonide and formoterol inhibit bronchial epithelial cell-mediated eosinophil superoxide production Source: Eur Respir J 2005; 26: Suppl. 49, 123s Year: 2005
Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine Source: Eur Respir J 2005; 26: Suppl. 49, 98s Year: 2005
Inhibitory activity of mometasone furoate and dexamethasone on ICAM-1 expression and eotaxin, IL-6 and MCP-1 release by human foetal lung fibroblasts induced by TNF-α Source: Eur Respir J 2001; 18: Suppl. 33, 406s Year: 2001
Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018